Hi Faye!
You know in Europe Vidaza isn’t approved for low risk MDS. I have seen results between 67% response to 38% response for low risk patients.
Here is one study:
http://www.ncbi.nlm.nih.gov/pubmed/23596104
High risk patients have better results often a little more than 50%.
Combinations of Vidaza with other drugs show much better results for example Vidaza + Pracinostat 89% response:
https://ash.confex.com/ash/2012/webp...aper50414.html . Only 9 patients had participated in this study when this report was written.
Vidaza + Revlimid has showed 72% response rate:
http://www.ncbi.nlm.nih.gov/pubmed/22915641
Kind regards
Birgitta-A